Mankind Pharma Limited (MANKIND.BO)
INR 2343.55
(-1.47%)
INR 2343.55
(-1.47%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 119.63 Billion INR | 23.14% |
| 2022 | 97.15 Billion INR | 6.21% |
| 2021 | 91.47 Billion INR | 43.55% |
| 2020 | 63.72 Billion INR | 25.61% |
| 2019 | 50.73 Billion INR | 23.36% |
| 2018 | 41.12 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 110.98 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 119.63 Billion INR | 23.14% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 119.63 Billion INR | 0.0% |
| 2022 Q4 | 97.15 Billion INR | 4.76% |
| 2022 FY | 97.15 Billion INR | 6.21% |
| 2022 Q3 | 92.73 Billion INR | 0.0% |
| 2021 Q4 | 91.47 Billion INR | 0.0% |
| 2021 FY | 91.47 Billion INR | 43.55% |
| 2020 FY | 63.72 Billion INR | 25.61% |
| 2019 FY | 50.73 Billion INR | 23.36% |
| 2018 FY | 41.12 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -85.604% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 73.457% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -319.703% |
| Granules India Limited | 55.2 Billion INR | -116.687% |
| Indoco Remedies Limited | 21.44 Billion INR | -457.798% |
| Achyut Healthcare Limited | 309.52 Million INR | -38550.741% |
| Ajanta Pharma Limited | 46.38 Billion INR | -157.918% |
| Alkem Laboratories Limited | 155.74 Billion INR | 23.189% |
| Alpa Laboratories Limited | 1.82 Billion INR | -6450.84% |
| Brooks Laboratories Limited | 904.45 Million INR | -13127.046% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -1009.735% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -1463.563% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -885.548% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 69.129% |
| Eris Lifesciences Limited | 70.48 Billion INR | -69.72% |
| FDC Limited | 24.68 Billion INR | -384.717% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 16.682% |
| Gufic Biosciences Limited | 10.92 Billion INR | -994.993% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -926.795% |
| Ipca Laboratories Limited | 111.01 Billion INR | -7.765% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -5411.04% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -6614.34% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -7829.58% |
| Laurus Labs Limited | 83.87 Billion INR | -42.64% |
| Lupin Limited | 239.97 Billion INR | 50.147% |
| Medicamen Biotech Limited | 2.94 Billion INR | -3961.917% |
| Medico Remedies Limited | 961.95 Million INR | -12336.423% |
| Megasoft Limited | 3.65 Billion INR | -3169.545% |
| NATCO Pharma Limited | 69.06 Billion INR | -73.222% |
| Piramal Pharma Limited | 153.11 Billion INR | 21.869% |
| RPG Life Sciences Limited | 5.12 Billion INR | -2232.61% |
| Sigachi Industries Limited | 6.94 Billion INR | -1623.423% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 86.002% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -430.736% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -2856.343% |
| Unichem Laboratories Limited | 31.69 Billion INR | -277.468% |
| Wanbury Limited | 3.43 Billion INR | -3382.822% |
| Windlas Biotech Limited | 6.26 Billion INR | -1810.434% |
| ZIM Laboratories Limited | 4.46 Billion INR | -2577.408% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 59.143% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -2222.782% |
| Divi's Laboratories Limited | 154.7 Billion INR | 22.668% |
| Hester Biosciences Limited | 6.62 Billion INR | -1706.191% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -1406.024% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -3160.891% |
| Bal Pharma Limited | 3.2 Billion INR | -3633.978% |
| Strides Pharma Science Limited | 58.39 Billion INR | -104.859% |
| Venus Remedies Limited | 6.26 Billion INR | -1808.533% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -363.315% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -446.004% |
| Shilpa Medicare Limited | 30.93 Billion INR | -286.759% |
| Aarti Drugs Limited | 24.32 Billion INR | -391.837% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -433.027% |
| Suven Life Sciences Limited | 2.84 Billion INR | -4099.067% |
| Ind-Swift Limited | 6.54 Billion INR | -1727.927% |
| Valiant Laboratories Limited | 3.42 Billion INR | -3391.012% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -199.521% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -408.867% |
| Themis Medicare Limited | 5.66 Billion INR | -2012.095% |
| Hikal Limited | 24.87 Billion INR | -381.004% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 20.568% |
| Sequent Scientific Limited | 15.4 Billion INR | -676.641% |
| Novartis India Limited | 9.24 Billion INR | -1193.423% |
| Wockhardt Limited | 76.49 Billion INR | -56.403% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -3.591% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -25309.024% |
| Neuland Laboratories Limited | 18.32 Billion INR | -552.816% |
| Morepen Laboratories Limited | 12.93 Billion INR | -825.086% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -4883.41% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -3487.998% |